Clinical Trials Directory

Trials / Completed

CompletedNCT03817749

Ketone Supplementation, Glucose Control, and Cardiovascular Function

The Effects of Exogenous Ketone Supplementation on Cardiovascular Function and Glucose Control

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
30 Years – 69 Years
Healthy volunteers
Not accepted

Summary

Post-prandial hyperglycemic excursions induce a cascade of deleterious effects on the body, including increased inflammation, production of reactive oxygen species, and impaired cardiovascular function. Ingestion of an exogenous oral ketone supplement blunts hyperglycemia in response to an oral glucose tolerance test. Accordingly, it is hypothesized that exogenous ketone supplement ingestion prior to a meal could be an effective strategy for blunting postprandial hyperglycemia. Therefore, the purpose of this study is to investigate the effect of short-term (14-days) pre-meal exogenous ketone supplementation on glucose control, cardiovascular function, inflammation, and oxidative stress in individuals at an elevated risk of type 2 diabetes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTExogenous ketone monoesterParticipants will consume 20g of the oral ketone monoester supplement 15 minutes prior to each meal of the day for 14 days. All meals will be provided throughout the 14-day supplementation period.

Timeline

Start date
2019-02-06
Primary completion
2020-03-01
Completion
2020-12-31
First posted
2019-01-25
Last updated
2021-04-28

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03817749. Inclusion in this directory is not an endorsement.